id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0583-0016,FDA,FDA-2011-N-0583,"Clarification of Orphan-Drug Exclusivity Following Catalyst Pharms., Inc. v. Becerra; Notification",Rule,Approval,2023-01-24T05:00:00Z,2023,1,2023-01-24T05:00:00Z,,2023-01-24T17:14:45Z,2023-01179,0,0,0900006485606066